EDTUTC-4 New YorkLog in Sign up

RNA
Atrium Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseOct 2, 2026 3:59:56 PM EDT

7.84USD-3.686%(-0.30)533,806

Pre-marketOct 2, 2026 8:53:30 AM EDT

8.62USD+5.897%(+0.48)

RNA News

Day breaks

02:00 PM EDTWave Life Sciences Names Monika Vnuk Chief Business Officer ·

RTTNews

10:22 AM EDTTsingke Enables High-Throughput Validation of AI-Designed Proteins and Antibodies ·

PR Newswire

08:04 AM EDTTransCode Therapeutics Announces Patent Advancements in Australia and Japan Strengthening Global IP Position in RNA-Based Immuno-Oncology ·

PR Newswire

04:30 PM EDTAtrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) ·

PR Newswire

09:48 AM EDTTempus and Recursion Extend Data Partnership Through November 2029 ·

Securities.io

09:14 AM EDTTempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model ·

Business Wire

08:30 AM EDTEnhancing Prime Editing Efficiency Through Modified pegRNAs, Upcoming Webinar Hosted by Xtalks ·

PR Newswire

08:04 AM EDTAgilent launches clinical lab systems for DNA, RNA analysis ·

Investing.com

08:00 AM EDTAgilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control ·

Business Wire

03:00 AM EDTModerna’s Bob Langer and AI pioneer Yann LeCun join board of Cellular Intelligence, bringing AI into medicine via a Parkinson’s drug ·

Fortune

09:48 AM EDTA norovirus breakthrough?; another women’s healthtech haul ·

Pharma Voice

04:44 AM EDTBioNTech Threw in the Towel on Its Colorectal Cancer Vaccine Trial. Should Investors Be Worried? ·

The Motley Fool

07:45 AM EDTFrom Lab to Three Continents: AgroSpheres and FMC Corporation Advance Bioinsecticide Pipeline Into Global Field Trials ·

Business Wire

12:58 PM EDTSkyhawk Therapeutics Announces Final Fifteen-Month Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease Patients ·

PR Newswire

12:00 PM EDTHDT Bio Receives ARPA-H GIVE Award to Lead Development of Automated, Point-of-Care Manufacturing for Personalized RNA Medicines ·

PR Newswire

10:19 AM EDTRactigen Therapeutics to Present First-in-Human RNA Activation Data in Duchenne Muscular Dystrophy as a Late-Breaking Oral Presentation at the 31st Annual Congress of the World Muscle Society ·

PR Newswire

10:19 AM EDTRactigen Therapeutics to Present First-in-Human RNA Activation Data in Duchenne Muscular Dystrophy as a Late-Breaking Oral Presentation at the 31st Annual Congress of the World Muscle Society ·

PR Newswire

05:30 AM EDTHow AI makes biological research more dangerous ·

Axios

07:00 AM EDTCloverleaf Bio Raises $33 Million Seed Financing to Advance Novel RNA-Based Cancer Therapeutics ·

GlobeNewswire Inc.

09:44 AM EDT$7+ Billion mRNA Vaccines Market Outlook, 2035: Opportunities, Strategies, Challenges ·

GlobeNewswire Inc.